highly significantP <0.01
In personal interviews conducted by a gynecologist, after already one month into Treatment A, a great majority of women receiving both Maca-GO and Placebo treatment (19 of 20) observed highly significant ( P <0.01) reduction in feeling discomfort typically observed in the early perimenopausal stage as assessed by answers given to the questions according to Kupperman’s Menopausal Index (KMI) and expressed by the total point score of this Index (Figure 2 ).